MEDIPRINT OPHTHALMICS Trademark

Trademark Overview


On Friday, June 4, 2021, a trademark application was filed for MEDIPRINT OPHTHALMICS with the United States Patent and Trademark Office. The USPTO has given the MEDIPRINT OPHTHALMICS trademark a serial number of 90754981. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by MediPrint Ophthalmics, Inc.. The MEDIPRINT OPHTHALMICS trademark is filed in the Pharmaceutical Products category with the following description:

Contact lens drug delivery devices containing pharmaceutical preparations for the treatment or prevention of diseases and conditions that affect the eye, including but not limited to allergies, astigmatism, cataracts, diabetic retinopathy, dry eye, dry eye discomfort, eye infections, eye inflammation, glaucoma, keratonconus, macular degeneration, myopia, presbyopia, hyperopia, or a combination thereof
mediprint ophthalmics

General Information


Serial Number90754981
Word MarkMEDIPRINT OPHTHALMICS
Filing DateFriday, June 4, 2021
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7013429
Registration DateTuesday, March 28, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements


Description of MarkThe mark consists of "MEDIPRINT" in bold blue stylized text, and "OPHTHALMICS" in gray stylized text. The letters "M" and "P" within the "MEDIPRINT" are capitalized, and the letter "O" in the "OPHTHALMICS" is situated within three concentric abstract circles. The concentric circles transition in color from blue to gray, and are depicted in a series of bubbles in graduated size and weight.
Goods and ServicesContact lens drug delivery devices containing pharmaceutical preparations for the treatment or prevention of diseases and conditions that affect the eye, including but not limited to allergies, astigmatism, cataracts, diabetic retinopathy, dry eye, dry eye discomfort, eye infections, eye inflammation, glaucoma, keratonconus, macular degeneration, myopia, presbyopia, hyperopia, or a combination thereof
Indication of Colors claimedThe color(s) blue and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"OPHTHALMICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code005
First Use Anywhere DateSaturday, December 10, 2022
First Use In Commerce DateSaturday, December 10, 2022

Trademark Owner History


Party NameMediPrint Ophthalmics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92131

Party NameMediPrint Ophthalmics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92131

Party NameMediPrint Ophthalmics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92131

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Friday, February 24, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, February 23, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 1, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, December 30, 2022USE AMENDMENT FILED
Monday, January 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 30, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 12, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 9, 2022ASSIGNED TO LIE
Friday, May 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 4, 2022NON-FINAL ACTION E-MAILED
Friday, March 4, 2022NON-FINAL ACTION WRITTEN
Sunday, February 20, 2022ASSIGNED TO EXAMINER
Friday, August 27, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, August 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 8, 2021NEW APPLICATION ENTERED